Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 173 articles: HTML format

Single Articles

May 2008
1. LINDEROTH J , Eden P, Ehinger M, Valcich J, et al
   Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
   Br J Haematol. 2008;141:423-32.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. SIMPSON CD , Gao J, Fernandez CV, Yhap M, et al
   Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. REY J , Xerri L, Bouabdallah R, Keuppens M, et al
   Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. HIRT C , Schuler F, Kiefer T, Schwenke C, et al
   Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. EVENS AM , Schumacker PT, Helenowski IB, Singh AT, et al
   Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. PARK HJ , Neelapu SS
   Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SENFF NJ , Kluin-Nelemans HC, Willemze R
   Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. JARES P , Campo E
   Advances in the understanding of mantle cell lymphoma.
   Br J Haematol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. NARESH KN , Menasce LP, Shenjere P, Banerjee SS, et al
   'Precursors' of classical Hodgkin lymphoma in samples of angioimmunoblastic T-cell lymphoma.
   Br J Haematol. 2008;141:124-6.
   PubMed     Related articles   
   
   
   
10. BAECKLUND E , Natkunam Y, Backlin C, Iliadou A, et al
    Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
    Br J Haematol. 2008;141:69-72.
    PubMed     Related articles    Abstract available
    
    
    
11. KWEE TC , Kwee RM, Verdonck LF, Bierings MB, et al
    Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma.
    Br J Haematol. 2008;141:60-8.
    PubMed     Related articles    Abstract available
    
    
    
12. BASECKE J , Podleschny M, Becker A, Seiffert E, et al
    Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
    Br J Haematol. 2008;141:52-9.
    PubMed     Related articles    Abstract available
    
    
    
13. COX MC , Nofroni I, Laverde G, Ferrari A, et al
    Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma.
    Br J Haematol. 2008;141:265-8.
    PubMed     Related articles   
    
    
    
14. FOX CP , McMillan AK, Bishton MJ, Haynes AP, et al
    IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
    Br J Haematol. 2008;141:244-8.
    PubMed     Related articles    Abstract available
    
    
    March 2008
15. ZENT CS , Ding W, Schwager SM, Reinalda MS, et al
    The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. GERRARD M , Cairo MS, Weston C, Auperin A, et al
    Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. BOULANGER E , Meignin V, Oksenhendler E
    Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles   
    
    
    
18. NELSON M , Horsman DE, Weisenburger DD, Gascoyne RD, et al
    Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. KELLY K , Murphy K, Farrell M, Rawluk D, et al
    Intracranial small lymphocytic lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles   
    
    
    
20. INGRAM W , Devereux S, Das-Gupta EP, Russell NH, et al
    Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. LAWRIE CH , Gal S, Dunlop HM, Pushkaran B, et al
    Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. NIENS M , Visser L, Nolte IM, van der Steege G, et al
    Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Br J Haematol. 2008;140:527-536.
    PubMed     Related articles    Abstract available
    
    
    February 2008
23. BRICE P
    Managing relapsed and refractory Hodgkin lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. BOULANGER E , Meignin V, Baia M, Molinier-Frenkel V, et al
    Mucosa-associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection.
    Br J Haematol. 2008;140:470-4.
    PubMed     Related articles   
    
    
    
25. SMITH SM , Grinblatt D, Johnson JL, Niedzwiecki D, et al
    Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
    Br J Haematol. 2008;140:313-319.
    PubMed     Related articles    Abstract available
    
    
    
26. BLEEKER WK , Munk ME, Mackus WJ, van den Brakel JH, et al
    Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.
    Br J Haematol. 2008;140:303-12.
    PubMed     Related articles    Abstract available
    
    
    January 2008
27. KERR JP , Turner M, Ashton-Key M, Mead GM, et al
    Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles   
    
    
    
28. YANO H , Ishida T, Imada K, Sakai T, et al
    Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF.
    Br J Haematol. 2008;.
    PubMed     Related articles   
    
    
    
29. TAJ MM , Messahel B, Mycroft J, Pritchard-Jones K, et al
    Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children.
    Br J Haematol. 2008;140:191-6.
    PubMed     Related articles    Abstract available
    
    
    
30. INGLE GS , Chan P, Elliott JM, Chang WS, et al
    High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.
    Br J Haematol. 2008;140:46-58.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
31. HAMADANI M , Magro CM, Porcu P
    CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Br J Haematol. 2008;140:122.
    PubMed     Related articles   
    
    
    December 2007
32. EVENS AM , Winter JN, Hou N, Nelson BP, et al
    A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. RIBERA JM , Oriol A, Morgades M, Gonzalez-Barca E, et al
    Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. FALLANCA F , Giovacchini G, Ponzoni M, Gianolli L, et al
    Cervical thymic hyperplasia after chemotherapy in an adult patient with Hodgkin lymphoma: a potential cause of false-positivity on [(18)F]FDG PET/CT scanning.
    Br J Haematol. 2007;.
    PubMed     Related articles   
    
    
    November 2007
35. KIM HN , Lee IK, Kim YK, Tran HT, et al
    Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. CARBONE A , Gloghini A
    KSHV/HHV8-associated lymphomas.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. O'CONNOR OA , Hamlin PA, Portlock C, Moskowitz CH, et al
    Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma.
    Br J Haematol. 2007;139:425-8.
    PubMed     Related articles    Abstract available
    
    
    
38. MADDOCKS-CHRISTIANSON K , Slager SL, Zent CS, Reinalda M, et al
    Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:398-404.
    PubMed     Related articles    Abstract available
    
    
    
39. FERRUCCI PF , Vanazzi A, Grana CM, Cremonesi M, et al
    High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
    Br J Haematol. 2007;139:590-9.
    PubMed     Related articles    Abstract available
    
    
    October 2007
40. DORES GM , Anderson WF, Curtis RE, Landgren O, et al
    Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. DUVAL A , Bergoin E, Maynadie M, Bonnotte B, et al
    Hypereosinophilia as a presenting feature of anaplastic large cell lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles   
    
    
    
42. MINAGAWA K , Yamamoto K, Nishikawa S, Ito M, et al
    Deregulation of a possible tumour suppressor gene, ZC3H12D, by translocation of IGK@ in transformed follicular lymphoma with t(2;6)(p12;q25).
    Br J Haematol. 2007;139:161-3.
    PubMed     Related articles   
    
    
    
43. FABBRI A , Lenoci M, Gozzetti A, Chitarrelli I, et al
    Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
    Br J Haematol. 2007;139:90-93.
    PubMed     Related articles    Abstract available
    
    
    
44. MARSHALL NA , Culligan DJ, Johnston PW, Millar C, et al
    CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
    Br J Haematol. 2007;139:81-9.
    PubMed     Related articles    Abstract available
    
    
    
45. PEGGS KS , Sureda A, Qian W, Caballero D, et al
    Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
    Br J Haematol. 2007;139:70-80.
    PubMed     Related articles    Abstract available
    
    
    
46. MA L , Xu G, Sotnikova A, Szczepanowski M, et al
    Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.
    Br J Haematol. 2007;139:217-23.
    PubMed     Related articles    Abstract available
    
    
    
47. BREITKREUTZ I , Raab MS, Vallet S, Hideshima T, et al
    Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma.
    Br J Haematol. 2007;139:55-63.
    PubMed     Related articles    Abstract available
    
    
    
48. CHANG H , Ning Y, Qi X, Yeung J, et al
    Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma.
    Br J Haematol. 2007;139:51-4.
    PubMed     Related articles    Abstract available
    
    
    
49. MUNEMASA S , Sakai A, Kuroda Y, Okikawa Y, et al
    Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not.
    Br J Haematol. 2007;139:41-50.
    PubMed     Related articles    Abstract available
    
    
    September 2007
50. MANN G , Attarbaschi A, Burkhardt B, Niggli F, et al
    Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. DE CASTRO AF , Junior AS, Horta Hde L, Neuenschwander LC, et al
    Primary intracerebral Hodgkin lymphoma.
    Br J Haematol. 2007;138:562.
    PubMed     Related articles   
    
    
    
52. HALL GW , Katzilakis N, Pinkerton CR, Nicolin G, et al
    Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.
    Br J Haematol. 2007;138:761-8.
    PubMed     Related articles    Abstract available
    
    
    
53. LI X , Pennisi A, Zhan F, Sawyer JR, et al
    Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
    Br J Haematol. 2007;138:802-11.
    PubMed     Related articles    Abstract available
    
    
    
54. HIDESHIMA T , Catley L, Raje N, Chauhan D, et al
    Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
    Br J Haematol. 2007;138:783-91.
    PubMed     Related articles    Abstract available
    
    
    
55. RENDTLEW DANIELSEN JM , Knudsen LM, Dahl IM, Lodahl M, et al
    Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma.
    Br J Haematol. 2007;138:756-60.
    PubMed     Related articles    Abstract available
    
    
    
56. MALUMBRES R , Davis J, Ruiz P, Lossos IS, et al
    Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
    Br J Haematol. 2007;138:749-55.
    PubMed     Related articles    Abstract available
    
    
    
57. NIESVIZKY R , Naib T, Christos PJ, Jayabalan D, et al
    Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naive patients undergoing front-line lenalidomide and dexamethasone therapy.
    Br J Haematol. 2007;138:640-3.
    PubMed     Related articles    Abstract available
    
    
    
58. LI QF , Wu CT, Duan HF, Sun HY, et al
    Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Br J Haematol. 2007;138:632-9.
    PubMed     Related articles    Abstract available
    
    
    
59. TRENTIN L , Miorin M, Facco M, Baesso I, et al
    Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Br J Haematol. 2007;138:594-602.
    PubMed     Related articles    Abstract available
    
    
    
60. PRATT G , Goodyear O, Moss P
    Immunodeficiency and immunotherapy in multiple myeloma.
    Br J Haematol. 2007;138:563-79.
    PubMed     Related articles    Abstract available
    
    
    
61. HUGHES D , Cappellini MD, Berger M, Van Droogenbroeck J, et al
    Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.
    Br J Haematol. 2007;138:676-86.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
62. COLAGRANDE M , Di Ianni M, Ciurnelli R, Gallucci M, et al
    Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis.
    Br J Haematol. 2007;138:812-3.
    PubMed     Related articles   
    
    
    
63. MA ES , Shek TW, Ma SY
    Non-secretory plasma cell myeloma of the true non-producer type.
    Br J Haematol. 2007;138:561.
    PubMed     Related articles   
    
    
    August 2007
64. WILLENBROCK K , Brauninger A, Hansmann ML
    Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. HIRT C , Dolken G, Janz S, Rabkin CS, et al
    Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals.
    Br J Haematol. 2007;138:349-53.
    PubMed     Related articles    Abstract available
    
    
    
66. LACOSTE V , Nicot C, Gessain A, Valensi F, et al
    In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
    Br J Haematol. 2007;138:487-501.
    PubMed     Related articles    Abstract available
    
    
    
67. KROPFF M , Bisping G, Schuck E, Liebisch P, et al
    Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
    Br J Haematol. 2007;138:330-7.
    PubMed     Related articles    Abstract available
    
    
    
68. ENRICO O , Gabriele B, Nadia C, Sara G, et al
    Unexpected cardiotoxicity in haematological bortezomib treated patients.
    Br J Haematol. 2007;138:396-7.
    PubMed     Related articles   
    
    
    
69. CHANG H , Yeung J, Qi C, Xu W, et al
    Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma.
    Br J Haematol. 2007;138:324-9.
    PubMed     Related articles    Abstract available
    
    
    
70. PONZONI M , Berger F, Chassagne-Clement C, Tinguely M, et al
    Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.
    Br J Haematol. 2007;138:316-23.
    PubMed     Related articles    Abstract available
    
    
    
71. MILES RR , Cairo MS, Satwani P, Zwick DL, et al
    Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
    Br J Haematol. 2007;138:506-12.
    PubMed     Related articles    Abstract available
    
    
    
72. LIGGINS AP , Cooper CD, Lawrie CH, Brown PJ, et al
    MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
    Br J Haematol. 2007;138:479-86.
    PubMed     Related articles    Abstract available
    
    
    
73. HECHT M , Heider U, Kaiser M, von Metzler I, et al
    Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Br J Haematol. 2007;138:446-58.
    PubMed     Related articles    Abstract available
    
    
    
74. CAMPBELL RA , Sanchez E, Steinberg JA, Baritaki S, et al
    Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
    Br J Haematol. 2007;138:467-78.
    PubMed     Related articles    Abstract available
    
    
    
75. THACHIL J , Jadhav V, Gautam M, McKew S, et al
    The development of sarcoidosis with the use of alemtuzumab - clues to T-cell immune reconstitution.
    Br J Haematol. 2007;138:559-60.
    PubMed     Related articles   
    
    
    July 2007
76. MACHACZKA M , Vaktnas J
    Haemophagocytic syndrome associated with Hodgkin lymphoma and Pneumocystis jiroveci pneumonitis.
    Br J Haematol. 2007;.
    PubMed     Related articles   
    
    
    
77. HEDSTROM G , Berglund M, Molin D, Fischer M, et al
    Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.
    Br J Haematol. 2007;138:68-71.
    PubMed     Related articles    Abstract available
    
    
    
78. ZHOU Y , Attygalle AD, Chuang SS, Diss T, et al
    Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load.
    Br J Haematol. 2007;138:44-53.
    PubMed     Related articles    Abstract available
    
    
    
79. FENG H , Langenau DM, Madge JA, Quinkertz A, et al
    Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish.
    Br J Haematol. 2007;138:169-75.
    PubMed     Related articles    Abstract available
    
    
    
80. SEBTI Y , Le Maux A, Gros F, De Guibert S, et al
    Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
    Br J Haematol. 2007;138:202-12.
    PubMed     Related articles    Abstract available
    
    
    
81. BARLOGIE B , Anaissie E, van Rhee F, Haessler J, et al
    Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
    Br J Haematol. 2007;138:176-85.
    PubMed     Related articles    Abstract available
    
    
    
82. ANDERSON KC , Hannah AL, Pazdur R, Farrell AT, et al
    A strategic framework for novel drug development in multiple myeloma.
    Br J Haematol. 2007;138:153-9.
    PubMed     Related articles   
    
    
    
83. LEVENGA TH , Timmer-Bonte JN
    Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.
    Br J Haematol. 2007;138:146-52.
    PubMed     Related articles    Abstract available
    
    
    
84. JOURDAN M , Moreaux J, Vos JD, Hose D, et al
    Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
    Br J Haematol. 2007;138:160-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
85. DAMM-WELK C , Schieferstein J, Schwalm S, Reiter A, et al
    Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. DANG NH , Fayad L, McLaughlin P, Romaguara JE, et al
    Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. GROGG KL , Morice WG, Macon WR
    Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma.
    Br J Haematol. 2007;137:416-22.
    PubMed     Related articles    Abstract available
    
    
    
88. TECCHIO C , Nadali G, Scapini P, Bonetto C, et al
    High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.
    Br J Haematol. 2007;137:553-9.
    PubMed     Related articles    Abstract available
    
    
    
89. BUDA G , Maggini V, Galimberti S, Martino A, et al
    MDR1 polymorphism influences the outcome of multiple myeloma patients.
    Br J Haematol. 2007;137:454-6.
    PubMed     Related articles    Abstract available
    
    
    
90. RICHARDSON PG , Sonneveld P, Schuster MW, Irwin D, et al
    Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
    Br J Haematol. 2007;137:429-35.
    PubMed     Related articles    Abstract available
    
    
    
91. NOLAN L , Lorigan P, Chilton S, Newman J, et al
    Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.
    Br J Haematol. 2007;137:436-42.
    PubMed     Related articles    Abstract available
    
    
    
92. BEHL D , Ristow K, Markovic SN, Witzig TE, et al
    Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
    Br J Haematol. 2007;137:409-15.
    PubMed     Related articles    Abstract available
    
    
    
93. HUGHES M , Doig A, Soutar R
    Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns.
    Br J Haematol. 2007;137:486-7.
    PubMed     Related articles   
    
    
    
94. LAWRIE CH
    MicroRNAs and haematology: small molecules, big function.
    Br J Haematol. 2007;137:503-12.
    PubMed     Related articles    Abstract available
    
    
    
95. SHAUGHNESSY JD JR , Haessler J, van Rhee F, Anaissie E, et al
    Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics.
    Br J Haematol. 2007;137:530-6.
    PubMed     Related articles    Abstract available
    
    
    
96. PAN Z , Shen Y, Ge B, Du C, et al
    Studies of a germinal centre B-cell expressed gene, GCET2, suggest its role as a membrane associated adapter protein.
    Br J Haematol. 2007;137:578-90.
    PubMed     Related articles    Abstract available
    
    
    May 2007
97. PULSONI A , Starza ID, Frattarelli N, Ghia E, et al
    Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Br J Haematol. 2007;137:216-220.
    PubMed     Related articles    Abstract available
    
    
    
98. HASSELBLOM S , Sigurdadottir M, Hansson U, Nilsson-Ehle H, et al
    The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma.
    Br J Haematol. 2007;137:364-73.
    PubMed     Related articles    Abstract available
    
    
    
99. NISHIO M , Fujimoto K, Yamamoto S, Endo T, et al
    Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
    Br J Haematol. 2007;137:349-54.
    PubMed     Related articles    Abstract available
    
    
    
100. LIETZ A , Janz M, Sigvardsson M, Jundt F, et al
     Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
     Br J Haematol. 2007;137:342-8.
     PubMed     Related articles    Abstract available
     
     
     
101. KORVER W , Singh S, Liu S, Zhao X, et al
     The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
     Br J Haematol. 2007;137:307-18.
     PubMed     Related articles    Abstract available
     
     
     
102. MORGAN GJ , Schey SA, Wu P, Srikanth M, et al
     Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients.
     Br J Haematol. 2007;137:268-9.
     PubMed     Related articles   
     
     
     
103. KYRTSONIS MC , Vassilakopoulos TP, Kafasi N, Sachanas S, et al
     Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
     Br J Haematol. 2007;137:240-3.
     PubMed     Related articles    Abstract available
     
     
     
104. LEE JJ , Kim DH, Lee NY, Sohn SK, et al
     Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
     Br J Haematol. 2007;137:329-36.
     PubMed     Related articles    Abstract available
     
     
     April 2007
105. EVENS AM , Cilley J, Ortiz T, Gounder M, et al
     G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
     Br J Haematol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. RETTER A , Ardeshna KM, O'driscoll A
     Cardiac tamponade in Hodgkin lymphoma.
     Br J Haematol. 2007;.
     PubMed     Related articles   
     
     
     
107. KWONG YL
     Predicting the outcome in non-Hodgkin lymphoma with molecular markers.
     Br J Haematol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. TAKEUCHI S , Hofmann WK, Tsukasaki K, Takeuchi N, et al
     Loss of H19 imprinting in adult T-cell leukaemia/lymphoma.
     Br J Haematol. 2007;.
     PubMed     Related articles   
     
     
     
109. HAYNES AP
     Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma - response to Lennard.
     Br J Haematol. 2007;137:171.
     PubMed     Related articles   
     
     
     
110. LENNARD A
     Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
     Br J Haematol. 2007;137:170.
     PubMed     Related articles   
     
     
     
111. PARRY-JONES N , Matutes E, Morilla R, Brito-Babapulle V, et al
     Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
     Br J Haematol. 2007;137:117-24.
     PubMed     Related articles    Abstract available
     
     
     
112. SINGH J , Fairbairn KJ, Williams C, Das-Gupta EP, et al
     Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patients.
     Br J Haematol. 2007;137:172-3.
     PubMed     Related articles   
     
     
     
113. AU GG , Lincz LF, Enno A, Shafren DR, et al
     Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.
     Br J Haematol. 2007;137:133-41.
     PubMed     Related articles    Abstract available
     
     
     
114. D'SA S , Abildgaard N, Tighe J, Shaw P, et al
     Guidelines for the use of imaging in the management of myeloma.
     Br J Haematol. 2007;137:49-63.
     PubMed     Related articles    Abstract available
     
     
     March 2007
115. HOFMAN MS , Fields P, Yung L, George Mikhaeel N, et al
     Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
     Br J Haematol. 2007;.
     PubMed     Related articles   
     
     
     
116. BISHTON MJ , Lush RJ, Byrne JL, Russell NH, et al
     Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease.
     Br J Haematol. 2007;136:752-61.
     PubMed     Related articles    Abstract available
     
     
     
117. OSTERBORG A , Steegmann JL, Hellmann A, Couban S, et al
     Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin's lymphoma receiving combination chemotherapy.
     Br J Haematol. 2007;136:736-44.
     PubMed     Related articles    Abstract available
     
     
     
118. MELE A , Offidani M, Visani G, Marconi M, et al
     Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
     Br J Haematol. 2007;136:729-35.
     PubMed     Related articles    Abstract available
     
     
     
119. KEIJZER A , Huijgens PC, van de Loosdrecht AA
     Palifermin and palmar-plantar erythrodysesthesia.
     Br J Haematol. 2007;136:856-7.
     PubMed     Related articles   
     
     
     
120. YING J , Gao Z, Li H, Srivastava G, et al
     Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
     Br J Haematol. 2007;136:829-32.
     PubMed     Related articles    Abstract available
     
     
     February 2007
121. TSUBOKURA M , Asada N, Odawara J, Aoki T, et al
     Identification of cardiac metastasis of primary gastric diffuse large B-cell lymphoma.
     Br J Haematol. 2007;.
     PubMed     Related articles   
     
     
     
122. DANG NH , Pro B, Hagemeister FB, Samaniego F, et al
     Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
     Br J Haematol. 2007;136:439-47.
     PubMed     Related articles    Abstract available
     
     
     
123. HISHIZAWA M , Okamoto K, Chonabayashi K, Kaneko H, et al
     Primary large B-cell lymphoma of the bone marrow.
     Br J Haematol. 2007;136:351.
     PubMed     Related articles   
     
     
     
124. GARNACHE-OTTOU F , Feuillard J, Saas P
     Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
     Br J Haematol. 2007;136:539-48.
     PubMed     Related articles    Abstract available
     
     
     
125. CAUWENBERGHS S , Feijge MA, Theunissen E, Heemskerk JW, et al
     Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
     Br J Haematol. 2007;136:480-90.
     PubMed     Related articles    Abstract available
     
     
     
126. YASUI H , Hideshima T, Ikeda H, Jin J, et al
     BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
     Br J Haematol. 2007;136:414-23.
     PubMed     Related articles    Abstract available
     
     
     
127. PINEDA-ROMAN M , Bolejack V, Arzoumanian V, Anaissie E, et al
     Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
     Br J Haematol. 2007;136:393-9.
     PubMed     Related articles    Abstract available
     
     
     
128. UCKUN F , Ozer Z, Vassilev A
     Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
     Br J Haematol. 2007;136:574-89.
     PubMed     Related articles    Abstract available
     
     
     
129. AGNELLI L , Fabris S, Bicciato S, Basso D, et al
     Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma.
     Br J Haematol. 2007;136:565-73.
     PubMed     Related articles    Abstract available
     
     
     
130. CHANDESRIS MO , Soulier J, Labaume S, Crinquette A, et al
     Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
     Br J Haematol. 2007;136:609-14.
     PubMed     Related articles    Abstract available
     
     
     
131. WU KL , Beverloo B, Lokhorst HM, Segeren CM, et al
     Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
     Br J Haematol. 2007;136:615-23.
     PubMed     Related articles    Abstract available
     
     
     
132. NEHRING AK , Dua U, Mollee P, Gill D, et al
     Epstein-Barr virus T-cell immunity despite rituximab.
     Br J Haematol. 2007;136:628-32.
     PubMed     Related articles    Abstract available
     
     
     January 2007
133. KUKREJA A , Hutchinson A, Mazumder A, Vesole D, et al
     Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications.
     Br J Haematol. 2007;136:106-10.
     PubMed     Related articles    Abstract available
     
     
     
134. ARCAINI L , Paulli M, Burcheri S, Rossi A, et al
     Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
     Br J Haematol. 2007;136:301-4.
     PubMed     Related articles    Abstract available
     
     
     
135. GARCIA-SUAREZ J , Banas H, Arribas I, De Miguel D, et al
     Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
     Br J Haematol. 2007;136:276-85.
     PubMed     Related articles    Abstract available
     
     
     
136. DAVIES AJ , Rosenwald A, Wright G, Lee A, et al
     Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
     Br J Haematol. 2007;136:286-93.
     PubMed     Related articles    Abstract available
     
     
     
137. AGBALIKA F , Larghero J, Esperou H, Marais D, et al
     Epstein-Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disorders.
     Br J Haematol. 2007;136:305-8.
     PubMed     Related articles    Abstract available
     
     
     
138. SHUSTIK C , Belch A, Robinson S, Rubin SH, et al
     A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.
     Br J Haematol. 2007;136:203-11.
     PubMed     Related articles    Abstract available
     
     
     
139. OWEN RG , Fan I, O'connor SJ, Rollett RA, et al
     Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?
     Br J Haematol. 2007;136:163-4.
     PubMed     Related articles   
     
     
     
140. HIDDEMANN W , Buske C, Dreyling M, Weigert O, et al
     Current management of follicular lymphomas.
     Br J Haematol. 2007;136:191-202.
     PubMed     Related articles    Abstract available
     
     
     
141. BAINS MA , Pardoe LE, Rudin CE
     Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma.
     Br J Haematol. 2007;136:179.
     PubMed     Related articles   
     
     
     
142. MURIS JJ , Ylstra B, Cillessen SA, Ossenkoppele GJ, et al
     Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
     Br J Haematol. 2007;136:38-47.
     PubMed     Related articles    Abstract available
     
     
     December 2006
143. THOMSON JJ , Walt JV, Ireland R
     Bone marrow trephine biopsy appearances of the intravascular subtype of diffuse large B-cell lymphoma.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
144. FERRUCCI PF , Zucca E
     Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
     Br J Haematol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
145. TERPOS E , Heath DJ, Rahemtulla A, Zervas K, et al
     Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
     Br J Haematol. 2006;135:688-92.
     PubMed     Related articles    Abstract available
     
     
     
146. PRUTCHI-SAGIV S , Golishevsky N, Oster HS, Katz O, et al
     Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
     Br J Haematol. 2006;135:660-672.
     PubMed     Related articles    Abstract available
     
     
     
147. PRIOLA SM , Priola AM, Cataldi A, Fava C, et al
     Nodular sclerosing Hodgkin disease presenting as a sternal mass.
     Br J Haematol. 2006;135:594.
     PubMed     Related articles   
     
     
     
148. BENNETT CL , Evens AM, Andritsos LA, Balasubramanian L, et al
     Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
     Br J Haematol. 2006;135:642-50.
     PubMed     Related articles    Abstract available
     
     
     November 2006
149. ODAWARA J , Asada N, Aoki T, Yamakura M, et al
     (18)F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
150. BISHTON MJ , Haynes AP
     Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
     Br J Haematol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
151. HART J , Robert Turner A, Larratt L, Russell J, et al
     Transmission of a follicular lymphoma by allogeneic bone marrow transplantation - evidence to support the existence of lymphoma progenitor cells.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
152. HERNANDEZ-MARAVER D , Hernandez-Navarro F, Gomez-Leon N, Coya J, et al
     Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
     Br J Haematol. 2006;135:293-302.
     PubMed     Related articles    Abstract available
     
     
     
153. FANNING SR , Rybicki L, Kalaycio M, Andresen S, et al
     Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies.
     Br J Haematol. 2006;135:374-81.
     PubMed     Related articles    Abstract available
     
     
     
154. FULCINITI F , Corazzelli G
     Postradiation mesothelioma: diagnosis on fine needle cytology sample.
     Br J Haematol. 2006;135:279.
     PubMed     Related articles   
     
     
     
155. CLOOSEN S , Gratama J, van Leeuwen EB, Senden-Gijsbers BL, et al
     Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma.
     Br J Haematol. 2006;135:513-6.
     PubMed     Related articles    Abstract available
     
     
     
156. CHANG H , Qi X, Trieu Y, Xu W, et al
     Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation.
     Br J Haematol. 2006;135:486-91.
     PubMed     Related articles    Abstract available
     
     
     October 2006
157. SAIF M , Jowitt S
     Yellow nails in non-Hodgkin lymphoma.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
158. PORRECA E , Guglielmi MD, Marano R, Di Nisio M, et al
     Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
159. BERENSON JR , Boccia R, Siegel D, Bozdech M, et al
     Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
     Br J Haematol. 2006;135:174-83.
     PubMed     Related articles    Abstract available
     
     
     
160. BELOV L , Mulligan SP, Barber N, Woolfson A, et al
     Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
     Br J Haematol. 2006;135:184-97.
     PubMed     Related articles    Abstract available
     
     
     
161. COAKLEY D
     Denis Burkitt and his contribution to haematology/oncology.
     Br J Haematol. 2006;135:17-25.
     PubMed     Related articles    Abstract available
     
     
     
162. BARLOGIE B , Tricot GJ, van Rhee F, Angtuaco E, et al
     Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
     Br J Haematol. 2006;135:158-64.
     PubMed     Related articles    Abstract available
     
     
     
163. RAJE N , Kumar S, Hideshima T, Ishitsuka K, et al
     Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
     Br J Haematol. 2006;135:52-61.
     PubMed     Related articles    Abstract available
     
     
     
164. CHEE LC , Fahey V, Juneja S, Lieschke GJ, et al
     Images in haematology. Relapsed blastic natural killer cell leukaemia with splenic rupture.
     Br J Haematol. 2006;135:2.
     PubMed     Related articles   
     
     
     September 2006
165. ZERVAS K , Verrou E, Teleioudis Z, Vahtsevanos K, et al
     Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.
     Br J Haematol. 2006;134:620-3.
     PubMed     Related articles    Abstract available
     
     
     
166. CUTTING RJ , Snowden JA
     Myeloma in monozygotic twin.
     Br J Haematol. 2006;134:646.
     PubMed     Related articles   
     
     
     
167. SIDDIQUI M , Ristow K, Markovic SN, Witzig TE, et al
     Absolute lymphocyte count predicts overall survival in follicular lymphomas.
     Br J Haematol. 2006;134:596-601.
     PubMed     Related articles    Abstract available
     
     
     
168. CHANG H , Yeung J, Xu W, Ning Y, et al
     Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
     Br J Haematol. 2006;134:613-5.
     PubMed     Related articles    Abstract available
     
     
     
169. CANALES MA , Martin A, Caballero D, Hernandez-Navarro F, et al
     Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.
     Br J Haematol. 2006;134:645-6.
     PubMed     Related articles   
     
     
     
170. JABLONSKI M , Servais A, Suarez F, Fakhouri F, et al
     Plasmacytoma in a multiple myeloma patient.
     Br J Haematol. 2006;134:451.
     PubMed     Related articles   
     
     
     June 2006
171. PRIETO-SANCHEZ RM , Hernandez JA, Garcia JL, Gutierrez NC, et al
     Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q.
     Br J Haematol. 2006;133:642-5.
     PubMed     Related articles    Abstract available
     
     
     
172. AL-ASSAR O , Rees-Unwin KS, Menasce LP, Hough RE, et al
     Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
     Br J Haematol. 2006;133:612-21.
     PubMed     Related articles    Abstract available
     
     
     January 2006
173. MOUNIER N , Spina M, Gisselbrecht C
     Modern management of non-Hodgkin lymphoma in HIV-infected patients.
     Br J Haematol. 2006;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: